Epidermal Growth Factor and Related Growth Factors

International Journal of Dermatology

Volumn 30, Issue 10, 1991, Pages 687-694

  Yates, Ruth A ^a   Nanney, Lillian B ^a   Gates, Ronald E ^a   King, Lloyd E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

CELL GROWTH; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; WOUND HEALING;

AMINO ACID SEQUENCE; EPIDERMAL GROWTH FACTOR; HUMAN; KERATINOCYTES; MOLECULAR SEQUENCE DATA; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SKIN DISEASES; TRANSFORMING GROWTH FACTOR ALPHA; WOUND HEALING;

EID: 0026336865     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1991.tb02609.x     Document Type: Review

References (82)

1. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new‐born animal
2. Isolation and structure of urogastrone and its relationship to epidermal growth factor
3. Epidermal growth factor
4. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes
5. Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor‐alpha and epidermal growth factor
6. Peptide growth factors are multifunctional
7. The epidermal growth factor family
8. The role of epidermal growth factor in carcinogenesis
9. Type a transforming growth factor/growth inhibitor induces the reversible inhibition of normal human prokeratinocyte proliferation in serum‐free medium
10. The EGF/TGF alpha receptor in skin
11. Transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture
12. Developmental expression of transforming growth factor alpha and beta in mouse fetus
13. Induction of transforming growth factor in activated human alveolar macro‐phages
14. Production and auto‐induction of transforming growth factor in human keratinocytes
15. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor
16. Similarity between the vaccinia virus 19K early protein and epidermal growth factor
17. Epidermal growth factor receptor occupancy inhibits vaccinia virus infection
18. Epidermal growth factor
19. Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins
20. Epidermal growth factor: Location of disulfide bonds
21. Enhancement of epidermal regeneration by biosynthetic epidermal growth factor
22. Epidermal and dermal effects of epidermal growth factor during wound repair
23. Acceleration of tensile strength of incisions treated with EGF and TGF‐beta
24. Epithelial wound healing enhanced by transforming growth factor‐alpha and vaccinia growth factor
25. Enhancement of wound healing by topical treatment with epidermal growth factor
26. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages
27. Production and auto‐induction of transforming growth factor‐alpha in human keratinocytes
28. Wound macrophages express TGF‐alpha and other growth factors in vivo: Analysis by mRNA phenotyping
29. Transforming growth factor‐beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin
30. The epidermal growth factor receptor gene and its product
31. Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in transforming growth alpha
32. Biosynthesis of the epidermal growth factor receptor in A‐431 cells
33. Biosynthesis of N‐ and O‐ linked oligosaccarides of the low density lipoprotein receptor
34. Presence of mannose phosphate on the epidermal growth factor receptor in A‐431 cells
35. Ligand‐induced transformation by a noninternalizing epidermal growth factor receptor
36. Genetic determinants of neoplastic transformation by the retroviral oncogene v‐erb‐B
37. Truncation of the human epidermal growth factor receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts
38. Identification of residues in the nucleotide binding site of the epidermal growth factor receptor kinase
39. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor
40. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto‐oncogene expression and DNA synthesis
41. Biological activities of the EGF receptor mutants with individually altered autophosphorylation sites
42. Alteration of the epidermal growth factor receptor by mutation of its primary carboxyl‐terminal site of tyrosine selfphosphorylation
43. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor
44. Selfphosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation
45. Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism
46. Signal transduction by allosteric receptor oligomerization
47. Evidence that autophosphorylation of solubilized receptor for epidermal growth factor is mediated by intermolecular cross‐phosphorylation
48. Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation
49. Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo
50. Activation of the epidermal growth factor receptor tyrosine protein kinase in the absence of receptor oligomerization
51. Ganglioside‐mediated modulation of cell growth
52. A novel ganglioside, De N‐acetyl‐GM3, acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth
53. Studies of inositol phospholipid‐specific phospholipase C
54. Protein terminology tangle
55. Immunolocalization of p35 (lipocortrin I) in human skin (Abstr)
56. Epidermal growth factor: The receptor and its function
57. 1251–labeled human epidermal growth factor (hEGF): Binding, internalization, and degradation in human fibroblasts
58. “Down Regulation” of epidermal growth factor receptor: Direct demonstration of receptor degeneration in human fibroblasts
59. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase
60. Identification of a phosphotyrosyl‐protein phosphatase in mouse epidermis
61. Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin
62. Altered 1251–epidermal growth factor binding and receptor distribution in psoriasis
63. The role of epidermal growth factor in skin diseases
64. Epidermal growth factor and related growth factors
65. Epidermal growth factor receptors in genetically induced hyperproliferative skin disorders
66. Immunolocalization of epidermal growth factor receptors in normal developing human skin
67. Epidermal growth factor receptor mRNA is not increased in psoriatic skin
68. Analysis of epidermal growth factor receptor gene in psoriasis
69. Melanoma, growth factors, acanthosis nigricans, the sign of Leser‐Trelat and multiple acrochordons: A role for transforming growth factor‐alpha in cutaneous paraneoplastic syndromes
70. Mechanisms by which EGF receptor and TGF alpha contribute to malignant transformation
71. Synthesis of messenger RNAs for transforming growth factors and the epidermal growth factor receptor by human factors
72. Stimulation by EGF of the growth of EGF receptor‐hyperproducing tumors in athymic mice
73. Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomas
74. Biology of the A‐431 cell: A useful organism for hormone research
75. Expression of epidermal growth factor receptors in human brain tumors
76. Growth‐inhibitory effects of epidermal growth factor and over expression of its receptors on human squamous cell carcinomas in culture
77. The neu gene: An erbB‐homologous gene distinct from and unlinked to the gene encoding the EGF receptor
78. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for over expression in a subset of human mammary tumors
79. The neu oncogene: An erb‐B‐related gene encoding a 185, 000–Mr tumor antigen
80. Studies of the HER‐2/neu proto‐oncogene in human breast and ovarian cancer